PAX Financial Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,131
Closed -$664K 234
2023
Q2
$664K Buy
14,131
+1,993
+16% +$93.7K 0.15% 118
2023
Q1
$509K Buy
+12,138
New +$509K 0.12% 145
2022
Q2
Sell
-11,944
Closed -$395K 200
2022
Q1
$395K Buy
+11,944
New +$395K 0.09% 156